Abbott's Similac Recall Triggers Overflow Demand For Answers
This article was originally published in The Tan Sheet
Executive Summary
Consumer response to Abbott Laboratories' recall of powder Similac and other infant formula products initially exceeded the firm's capabilities to handle telephone calls and support online traffic to its websites
You may also be interested in...
Abbott Nutritionals Rise In Stature With Departure Of Branded Rx
Abbott Laboratories’ nutrition business – one of four divisions in the remaining diversified medical products firm – gains importance with the firm’s plan to spin off its research-based branded pharmaceuticals business.
Abbott Nutritionals Rise In Stature With Departure Of Branded Rx
Abbott Laboratories’ nutrition business – one of four divisions in the remaining diversified medical products firm – gains importance with the firm’s plan to spin off its research-based branded pharmaceuticals business.
Abbott Nutritionals Rise In Stature With Departure Of Branded Rx
Abbott Laboratories’ nutrition business – one of four divisions in the remaining diversified medical products firm – gains importance with the firm’s plan to spin off its research-based branded pharmaceuticals business.